Valuation: Balaxi Pharmaceuticals Limited

Market Cap 1.28B 13.31M 11.53M 10.9M 9.87M 18.52M 18.66M 130M 50.04M 647M 49.98M 48.87M 2.06B P/E 2025
14.1x
P/E 2026 61.1x
Enterprise Value 1.69B 17.59M 15.24M 14.41M 13.04M 24.48M 24.67M 172M 66.15M 856M 66.08M 64.61M 2.73B EV / Sales 2025
1.16x
EV / Sales 2026 0.47x
Free-Float
90.84%
Yield 2025 *
-
Yield 2026 -
1 day+1.12%
1 week-1.27%
Current month+4.66%
1 month-3.43%
3 months-0.30%
6 months+32.31%
Current year-12.99%
1 week 22.5
Extreme 22.5
24.8
1 month 21.5
Extreme 21.5
26.99
Current year 15.2
Extreme 15.2
29.9
1 year 15.2
Extreme 15.2
47.71
3 years 15.2
Extreme 15.2
151.45
5 years 15.2
Extreme 15.2
151.45
10 years 2.58
Extreme 2.58
216.04
Manager TitleAgeSince
Chief Executive Officer 56 2017-05-03
Director of Finance/CFO - 2021-05-19
Compliance Officer - 2026-03-24
Director TitleAgeSince
Chairman 56 2017-05-03
Director/Board Member 54 -
Director/Board Member 44 2017-05-03
Change 5-day change 1-year change 3-year change Capi.($)
+0.69%-1.27%-49.23%-74.42% 13.31M
-1.25%+1.17%+27.98%+114.11% 105B
-0.95%-3.26%+54.82%+165.13% 54.11B
-1.89%-3.00%-13.95%+240.79% 21.66B
-0.86%-2.17%-10.59%-9.14% 8.02B
-1.02%-4.07%-38.64%-36.26% 6.84B
+0.12%-4.66%-3.52%+13.01% 6.36B
-0.33%-4.27%-20.01%-31.21% 6B
-0.12%-1.02%-3.96%+18.39% 5.02B
-9.94%-32.63%+206.06%+347.61% 3.72B
Average -1.52%-2.85%+14.90%+74.80% 21.66B
Weighted average by Cap. -1.28%-1.22%+27.02%+125.00%

Financials

2025 2026
Net sales 2.93B 30.5M 26.42M 24.98M 22.62M 42.45M 42.77M 298M 115M 1.48B 115M 112M 4.73B 2.7B 28.17M 24.4M 23.07M 20.89M 39.2M 39.49M 275M 106M 1.37B 106M 103M 4.37B
Net income 251M 2.61M 2.26M 2.14M 1.94M 3.64M 3.66M 25.55M 9.83M 127M 9.82M 9.6M 405M 14.17M 148K 128K 121K 110K 206K 207K 1.44M 555K 7.18M 555K 543K 22.91M
Net Debt 127M 1.33M 1.15M 1.09M 983K 1.85M 1.86M 12.96M 4.99M 64.51M 4.98M 4.87M 206M 411M 4.29M 3.71M 3.51M 3.18M 5.96M 6.01M 41.89M 16.11M 208M 16.1M 15.74M 665M
Logo Balaxi Pharmaceuticals Limited
Balaxi Pharmaceuticals Limited is an India-based company. The Company operates as an intellectual property right (IPR)-based pharmaceutical company. The Company primarily operates in frontier markets across the Americas, Africa and the Caribbean islands. The Company is focusing on frontier markets, with a growing portfolio of drugs across multiple therapeutic segments. It is engaged in International Wholesale Distribution of Pharmaceuticals. The Company’s products include Anti-biotic, Analgesic, Medical Device, Vitamins, Anti-Malaria, Erectile Dysfunction, Hypertension, Anti-Asthma, Steroid, Anti-Helminthic, Anti-Ulcer, Hygiene, Anticholinergic, Dietary Supplement, Diuretic, Hormone, Anti-Emetic, Bronchodilator, Local Anesthetic, Anemia, Anti-Diarrhea, Antihistamine, Hypotension, Antacid, Anti-Tuberculosis, Insect Repellents, and Laxative. Its Boadent brand includes anticavity dental toothpaste. Its subsidiaries are Balaxi Global DMCC, Dubai and Balaxi healthcare Ecuador.
Employees
500
Date Price Change Volume
26-09-16 23.28 +0.69% 15,631
26-09-15 ₹23.12 -1.15% 26,067
26-09-11 ₹23.39 +0.65% 39,705
26-09-10 ₹23.24 -1.86% 39,290
26-09-09 ₹23.68 +1.46% 87,548
  1. Stock Market
  2. Stocks
  3. BALAXI Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!